# Equine Drugs and Supplements Market and Forecast 2025-2033

Limited-Time Offer \[Flat 15% Discount\] [Dismiss](#)

[Skip to content](#content "Skip to content")

[Updated Data Matrix Available](https://www.ihealthcareanalyst.com/research-services/)

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

[Home](https://www.ihealthcareanalyst.com/) » [Reports](https://www.ihealthcareanalyst.com/shop/) » [Animal Healthcare](https://www.ihealthcareanalyst.com/reports/animal-health/)

![Awaiting product image](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)

![Awaiting product image](https://www.ihealthcareanalyst.com/wp-content/uploads/2019/08/report-icon4-e1565791186498.png)

# Equine Drugs and Supplements Market by Pharmaceutical Drugs (Anti-Anxiety and Sedative Drugs, Nonsteroidal Anti-Inflammatory Drugs, Tranquilizers, Other Drugs), Supplements (Gastric and Ulcer Supplements, Joint Supplements, Minerals and Vitamins, Other Supplements), Distribution Channels (Drugstores, Veterinary Hospitals, Others) and Forecast 2025-2033

$3,000.00

## Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Nine types of drugs commonly administered to horses include analgesics (flunixin meglumine), anthelmintics (fenbendazole, ivermectin, moxidectin, oxfendazole, oxibendazole, praziquantel, pyrantel pamoate, pyrantel tartrate), antibiotics (gentamicin, penicillin, tetracycline, trimethoprim sulfa), antipyretics (ketoprofen, phenylbutazone), bronchodilators (albuterol, clenbuterol), corticosteroids (dexamethasone, prednisone), NSAIDs (flunixin meglumine, naproxen, phenylbutazone), sedatives (detomidine, xylazine), and tranquilizers (acetylpromazine, promazine). Equine joint supplements have been purported to decrease inflammation, increase mobility, provide the building blocks for articular cartilage synthesis, and/or contribute to the overall health of movable joints by some other mechanism. These supplements often are used for young, athletic horses to try to protect the healthy horse from injury, for treatment for a joint injury, and in older horses to try to counteract a lifetime of joint wear-and-tear. Veterinary nutritional supplements or nutraceuticals contain one or more dietary ingredients intended to supplement the diet. Such ingredients include vitamins, minerals, herbs or other botanical products, amino acids (the building blocks for proteins), and substances such as enzymes, organ tissues, glandulars, metabolites, extracts, or concentrates. Nutritional supplements for horses are available in a number of formulations, including pellets, granules, powders, pastes, liquids, injections (intravenous or intramuscular), and pills.

The global equine drugs and supplements market segmentation is based on pharmaceutical drugs (anti-anxiety and sedative drugs, nonsteroidal anti-inflammatory drugs, tranquilizers, others), supplements (gastric and ulcer supplements, joint supplements, minerals and vitamins, other supplements), and distribution channel (drugstores, veterinary hospitals, others).

The major equine drugs and supplements by brand include anti-anxiety and sedative drugs – clomipramine (clomicalm), detomidine (dormosedan), diazepam (valium), fentanyl, fluoxetine (prozac), pethidine, romifidine (sedivet), xylazine (rompun); nonsteroidal anti-inflammatory drugs (NSAIDs)  – firocoxib (equioxx), flunixin , flunixin meglumine (banamine), ketoprofen (ketofen), phenybutazone (bute); tranquilizers – acepromazine, fluphenazine, promace, reserpine, valium, xanax (alprazolam); by supplement type into gastric and ulcer supplements – gastro guard, ulcer guard; joint supplements – adequan, legend, pentosane; minerals and vitamins; other supplements and other drugs and supplements.

The global equine drugs and supplements market report provides market size ($Million 2023 to 2033), market share, trends and forecast (CAGR%, 2025 to 2033). The global equine drugs and supplements market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global equine drugs and supplements market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.

Major players operating in the equine drugs and supplements market and included in this report are Bayer Animal Health, Boehringer Ingelheim, Elanco (Eli Lilly), Merck Animal Health, Merial, Novartis Animal Health, and Zoetis.

**DATA INCLUDED:** Equine Drugs and Supplements Market Size, Equine Drugs and Supplements Market Share, Equine Drugs and Supplements Market Growth Rates, Equine Drugs and Supplements Market Trends, and Equine Drugs and Supplements Market Forecast to 2033

**Market Data:**

*   Estimation Base Year: 2024
*   Historical Data Range: 2023-2024
*   Forecast Period: 2025-2033
*   Market Representation: Revenue in $million and CAGR % from 2025 to 2033
*   Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
*   Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
*   Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
*   Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

**Qualitative Analysis:**

*   Industry Overview
*   Industry Trends
*   Market Driver, Restraints, and Opportunities
*   Market Size
*   Growth Trends
*   Porter’s Five Forces Analysis
*   Market Attractiveness Matrix
*   Competitive Landscape
    *   Company Overview
    *   Financial Performance
    *   Product Portfolio
    *   Strategic Insights
    *   Recent Developments

**Quantitative Analysis:**

*   Market Size Projections: Comprehensive estimates and forecasts for all segments
*   Regional Market Analysis: Estimates and forecasts for key countries
*   Corporate Financial Performance: Analysis of company financials
*   Competitive Landscape: Market share analysis of leading companies

Choose License Type

Choose an optionSingle-user LicenseMulti-user LicenseCorporate License[Clear](#)

Equine Drugs and Supplements Market by Pharmaceutical Drugs (Anti-Anxiety and Sedative Drugs, Nonsteroidal Anti-Inflammatory Drugs, Tranquilizers, Other Drugs), Supplements (Gastric and Ulcer Supplements, Joint Supplements, Minerals and Vitamins, Other Supplements), Distribution Channels (Drugstores, Veterinary Hospitals, Others) and Forecast 2025-2033 quantity 

Buy Report   

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

*   [Table of Contents AH](#tab-table-of-contents-ah)
*   [Market Segments and Companies](#tab-market-segments-and-companies)
*   [Request ToC / Sample](#tab-request-toc-sample-pages)

1.  **Introduction**
2.  **Executive Summary**
    *   Market Size Estimation ($million, 2021-2031)
    *   Forecast Estimation ($million and CAGR%, 2025-2031)
3.  [**Research Methodology**](https://www.ihealthcareanalyst.com/research-methodology/)
4.  **Market Landscape**
    *   Market Dynamics
        *   Drivers
        *   Barriers
        *   Opportunities
    *   Market Share Analysis
        *   Companies
        *   Drugs
    *   Market Trends Analysis
        *   Key success factors
        *   Market Growth Rate
    *   Market Attractiveness Analysis
    *   Market Profitability Analysis
        *   Buyer power
        *   Supplier power
        *   Barriers to entry
        *   Threat of substitute products
        *   Rivalry among firms in the industry
    *   Distribution Channels
5.  **Market Segmentation** \[_refer_ _Market Segments and Companies Tab_\]
    *   Animal Species Type
    *   Product Type (Diagnostic or Therapeutic)
    *   Diagnostic Test
    *   Indication Type
    *   Technology
    *   Diagnostics, Therapeutic or Surgical Application
    *   End User Groups
6.  **Geography (Region, Country)**
    *   North America (U.S., Canada)
    *   Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    *   Asia Pacific (Japan, China, India, Rest of APAC)
    *   Latin America (Brazil, Mexico, Rest of LA)
    *   Rest of the World (Middle East & Africa)
7.  **Company Profiles** \[_refer_ _Market Segments and Companies Tab_\]
    *   Company Overview
    *   Financial Snapshot
    *   Product Portfolio
    *   Business Strategies
    *   Recent Developments
8.  **Recommendations**
9.  **References**

**Key Questions Answered:**  
1\. What are the factors driving and limiting this market, key success factors and challenges?  
2\. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?  
3\. How do markets perform between countries and regions?  
4\. What market segments are contributing to maximum share and greatest growth?  
5\. What is the product or procedure volumes by country and regions?

**Actionable Insights Included:**  
1\. Product portfolio matrix (Share vs. Growth)  
2\. Market attractiveness (Region vs. Growth)  
3\. Spot matrix (Product vs. Region)  
4\. Geographic distribution matrix (Share vs. Growth)

**Equine Drugs and Supplements Market**

1\. **Drug Type**  
1.1. Anti-Anxiety and Sedative Drugs  
1.1.1. Clomipramine (Clomicalm)  
1.1.2. Detomidine (Dormosedan)  
1.1.3. Diazepam (Valium)  
1.1.4. Fentanyl  
1.1.5. Fluoxetine (Prozac)  
1.1.6. Pethidine  
1.1.7. Romifidine (SediVet)  
1.1.8. Xylazine (Rompun)  
1.1.9. Others  
1.2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)  
1.2.1. Firocoxib (Equioxx)  
1.2.2. Flunixin  
1.2.3. Flunixin Meglumine (Banamine)  
1.2.4. Ketoprofen (Ketofen)  
1.2.5. Phenybutazone (Bute)  
1.2.6. Others  
1.3. Tranquilizer  
1.3.1. Acepromazine  
1.3.2. Fluphenazine  
1.3.3. PromAce  
1.3.4. Reserpine  
1.3.5. Valium  
1.3.6. Xanax (Alprazolam)  
1.4. Other Drugs

2\. **Supplement Type**  
2.1. Gastric and Ulcer Supplements  
2.1.1. Gastro Guard  
2.1.2. Ulcer Guard  
2.2. Joint Supplements  
2.2.1. Adequan  
2.2.2. Legend  
2.2.3. Pentosan  
2.3. Minerals and Vitamins  
2.4. Other Supplements

3\. **Distribution Channel**  
3.1. Drug Stores  
3.2. Veterinary Hospitals  
3.3. Others

4\. **Company Profiles**  
4.1. Bayer Animal Health  
4.2. Boehringer Ingelheim  
4.3. Elanco (Eli Lilly)  
4.4. Merck Animal Health  
4.5. Merial  
4.6. Novartis Animal Health  
4.7. Zoetis

**Request Table of Contents / Sample Report**

Full Name\*

Company Email\*

Phone Number\* \[Please add country code\]

Subject\*

Message\*

Resource Links

*   [About Us](https://www.ihealthcareanalyst.com/about/)
*   [Clinical Trials](https://www.ihealthcareanalyst.com/clinical-trials-dashboard/)
*   [Drugs@FDA](https://www.ihealthcareanalyst.com/drugs-fda-dashboard/)
*   [Orange Book](https://www.ihealthcareanalyst.com/orange-book-dashboard/)
*   [Premarket Approval](https://www.ihealthcareanalyst.com/premarket-approval-pma/)
*   [Premarket Notification](https://www.ihealthcareanalyst.com/premarket-notification-510k/)
*   [Publications](https://www.ihealthcareanalyst.com/publications/)

Terms and Conditions

*   [FAQs](https://www.ihealthcareanalyst.com/faqs/)
*   [Careers](https://www.ihealthcareanalyst.com/careers/)
*   [Terms of Use](https://www.ihealthcareanalyst.com/terms/)
*   [How to Order](https://www.ihealthcareanalyst.com/order/)
*   [Return Policy](https://www.ihealthcareanalyst.com/return/)
*   [Privacy Policy](https://www.ihealthcareanalyst.com/privacy/)
*   [Disclaimer Policy](https://www.ihealthcareanalyst.com/disclaimer/)

Secure Online Payment

![iHealthcareAnalyst, Inc.](https://www.ihealthcareanalyst.com/wp-content/uploads/2018/07/creditcard-payment-logos-300x48.jpg)

Search

Search

Contact Address

**US Office:** 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States  
Phone: +1 (314) 315-4764  
**India Office:** 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India  
Phone: +91 (20) 25898524  
Email: [\[email protected\]](/cdn-cgi/l/email-protection#4635272a2335062f2e23272a322e252734232728272a3f35326825292b)

[](# "Scroll back to top")

Search for: